Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women
- PMID: 9072603
Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women
Abstract
Purpose: We evaluated and compared the efficacy of post-intercourse and daily oral ciprofloxacin prophylaxis against recurrent lower urinary tract infections in 135 sexually active premenopausal women.
Materials and methods: Post-intercourse (group 1, 70 patients) and daily (group 2, 65 patients) prophylactic regimens of 125 mg. ciprofloxacin were started following a curative, conventional treatment of the initial acute urinary tract infection. Prophylaxis was maintained for 12 months and during this period patients were followed clinically and bacteriologically with urine and introital samples. Patients were subsequently followed for an additional year after the end of preventive treatment.
Results: While 3.67 urinary tract infections per patient in group 1 and 3.74 in group 2 occurred during an identical mean time of 12.2 months before start of the corresponding prophylactic regimen, only 0.043 infection per patient in group 1 and 0.031 in group 2 developed during prophylaxis (p < 0.0001). Before prophylaxis 86% of the vaginal vestibule cultures yielded gram-negative Enterobacteriaceae, equally distributed between both treatment arms, compared to 5.6% and 2.5% during postcoital and daily prophylaxis, respectively. The overall improvement in the incidence of the urinary infections per patient and the rate of introital colonization with enteric gram-negative bacteria was maintained after the end of prophylaxis, with a mean incidence of infections of 0.44 per patient (occurring in 34% of the total patient population), while 36% of all women had abnormal introital colonization.
Conclusions: Long-term post-intercourse prophylaxis with ciprofloxacin proved to be equally effective as daily prophylaxis, and the major advantage of the former therapy was use of only a third of the amount of drug consumed in daily prophylaxis.
Similar articles
-
[Oral therapy with ciprofloxacin in the prophylaxis of urinary infections in surgical patients with permanent bladder catheter].Minerva Chir. 1996 Jul-Aug;51(7-8):625-8. Minerva Chir. 1996. PMID: 8975169 Clinical Trial. Italian.
-
Effective postcoital quinolone prophylaxis of recurrent urinary tract infections in women.J Urol. 1994 Jul;152(1):136-8. doi: 10.1016/s0022-5347(17)32837-9. J Urol. 1994. PMID: 8201643 Clinical Trial.
-
Once-daily fleroxacin versus twice-daily ciprofloxacin in the treatment of complicated urinary tract infections.J Urol. 1997 Oct;158(4):1494-9. J Urol. 1997. PMID: 9302150 Clinical Trial.
-
Oral fleroxacin prophylaxis in transurethral surgery.J Urol. 1996 Jul;156(1):146-8. J Urol. 1996. PMID: 8648777 Review.
-
Preventing infective sequelae of abortion.Hum Reprod. 1997 Nov;12(11 Suppl):107-12. Hum Reprod. 1997. PMID: 9433966 Review.
Cited by
-
Antibiotics for Preventing Recurrent Urinary Tract Infection: Systematic Review and Meta-analysis.Open Forum Infect Dis. 2022 Jul 3;9(7):ofac327. doi: 10.1093/ofid/ofac327. eCollection 2022 Jul. Open Forum Infect Dis. 2022. PMID: 35899289 Free PMC article. Review.
-
The etiology and management of recurrent urinary tract infections in postmenopausal women.Climacteric. 2019 Jun;22(3):242-249. doi: 10.1080/13697137.2018.1551871. Epub 2019 Jan 9. Climacteric. 2019. PMID: 30624087 Free PMC article. Review.
-
Uncomplicated Bacterial Community-Acquired Urinary Tract Infection in Adults.Dtsch Arztebl Int. 2017 Dec 15;114(50):866-873. doi: 10.3238/arztebl.2017.0866. Dtsch Arztebl Int. 2017. PMID: 29271346 Free PMC article.
-
[Urinary tract infections : What has been confirmed in therapy?].Internist (Berl). 2017 Dec;58(12):1242-1249. doi: 10.1007/s00108-017-0340-y. Internist (Berl). 2017. PMID: 29038902 Review. German.
-
Non-surgical management of recurrent urinary tract infections in women.Transl Androl Urol. 2017 Jul;6(Suppl 2):S142-S152. doi: 10.21037/tau.2017.06.09. Transl Androl Urol. 2017. PMID: 28791233 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical